Cadence Minerals #KDNC – Clancy Exploration update on Austrian Leogang Cobalt-Nickel Sulphide project

Cadence Minerals Plc (AIM/NEX: KDNC; OTC: KDNCY) reports that Australian listed Clancy Exploration Limited (ASX: CLY), has provided an update on its exploration licence at ground tenures at the Leogang Cobalt-Nickel Sulphide Project in Austria.

As previously announced, Clancy’s investigations into its tenure (announced 5 September 2017) determined that there were 28 overlapping licences out of Clancy’s 200 licences that were preceding priority claimants. These Preceding Claims cover a total area of approximately 12km2 and included the historical Nockelberg and Leogang mines. Clancy continues to have priority over the balance of the project area, being 172 licences covering approximately 68km2. 

Prior to the investigations, Cadence acquired a 10% interest (refer to ASX release dated 3 July 2017) in all 200 licences held by Clancy, and the parties entered into a joint venture. Cadence was subsequently made aware of the licensing situation and we agreed with Clancy to continue to evaluate the Remaining Licenses, in which Cadence holds 10%.

Furthermore. the board of Clancy, in discussions with Cadence, have considered it appropriate to issue Cadence 140,000,000 fully paid ordinary shares at a deemed price of $0.003 as compensation for the discovery of third party priority over the 28 overlapping licenses (including the historical Nockelberg and Leogang mines).

Once these Clancy shares are issued, Cadence will own approximately 4 % of Clancy.

The full Clancy Exploration announcement can be found at:

– Ends –

For further information, please contact.

Cadence Minerals plc

+44 (0) 207 440 0647

Andrew Suckling

Kiran Morzaria

WH Ireland Limited (NOMAD & Broker)

+44 (0) 207 220 1666

James Joyce

James Sinclair-Ford

Hannam & Partners LLP (Joint Broker)

+44 (0) 207 907 8500

Neil Passmore

Giles Fitzpatrick

Square1 Consulting

+44 (0) 207 929 5599

David Bick

Qualified Person

Kiran Morzaria B.Eng. (ACSM), MBA, has reviewed and approved the information contained in this announcement. Kiran holds a Bachelor of Engineering (Industrial Geology) from the Camborne School of Mines and an MBA (Finance) from CASS Business School.

About Cadence Minerals:

Cadence is dedicated to smart investments for a greener world. The planet needs rechargeable batteries on a global scale – upcoming supersized passenger vehicles, lorries and buses – require lithium and other technology minerals to power their cells. Cadence is helping find these minerals in new places and extracting them in new ways, which will meet the demand of this burgeoning market. With over £20 million vested in key assets globally, Cadence is helping us reach tomorrow, today. 

Cadence invests across the globe, principally in lithium mining projects. Its primary strategy is taking significant economic stakes in upstream exploration and development assets within strategic metals. We identify assets that have strategic cost advantages that are not replicable, with the aim of achieving lower quartile production costs. The combination of this approach and seeking value opportunities allows us to identify projects capable of achieving high rates of return.

The Cadence board has a blend of mining, commodity investing, fund management and deal structuring knowledge and experience, that is supported by access to key marketing, political and industry contacts. These resources are leveraged not only in our investment decisions but also in continuing support of our investments, whether it be increasing market awareness of an asset, or advising on product mix or path to production. Cadence Mineral’s goal is to assist management to rapidly develop the project up the value curve and deliver excellent returns on its investments.

Ian Pollard – “Good Progress” at Kingfisher #KGF as profits & earnings dive

Kingfisher KGF claims to have delivered key strategic milestones for the second year in a row as  statutory profit before tax fall by 10.1% and basic earnings per share by 18.5%. Definately a milestone of some sort there. Even the CEO joins in claiming this is all good progress.On a reported and adjusted basis earnings per share fell by 10.7% and like for like sales on a constant currency basis were down by 0.7%. Dividends for the full year are to be increased by 4%. The company claims that it is aware of the challenges ahead and is ready for another big year of implementations in 2018-19. The shareholders will perhaps be hoping that the Board learns that falls are a bad thing and in many companies are not regarded as “good progress.”

GKN plc GKN fights back against some of the more dubious claims made by Melrose in an attempt to ensure that GKN shareholders have information which is both complete and correct and that they will not be influenced by Melroses misleading statements. GKN scathingly  makes the point that Melrose has failed to disclose any plans for GKN’s aerospace business but at the same time is lambasting GKN for having copied those non existent plans. It points out that Melrose is a novice in automotive, without experience as a tier one supplier, only minimal experience in aerospace and only a minimal track record in both automotive and aerospace.

If words are anything to go by GKN must be winning hands down by the clarity and factual nature of its responses which compare well with the frenzied attitude adopted by Melrose. Unfortunately this battle between behemoths will not be won by words but as is usual in these cicumstances, by greed.

Softcat SCT In the six months to the 31st January Softcat enjoyed strong growth, robust customer demand, strong cash generation and profitable gains in market share. Revenue for the half year rose by 24.9%, operating profit by 19.1% and the interim dividend is to be increased by 13.8% to 3.3p per share.

Find beachfront villas & houses for sale in Greece;

Prairie Mining #PDZ – Lansdowne Partners become a substantial shareholder

Becoming a substantial holder

RNS Number : 3709I
Prairie Mining Limited
21 March 2018

TR-1: Standard form for notification of major holdings


NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Prairie Mining Ltd

Sedol BYSQ580

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an “X”)

An acquisition or disposal of voting rights


An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv


1Lansdowne Partners International Limited

2Lansdowne Partners Limited

3Lansdowne Partners (UK) LLP

4Lansdowne Developed Markets Master Fund Limited


City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v



City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reachedvi:


6. Date on which issuer notified (DD/MM/YYYY):


7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached




Position of previous notification (if





8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
ISIN code (if possible)
Number of voting rightsix
% of voting rights
(Art 9 of Directive 2004/109/EC) (DTR5.1)
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
(Art 9 of Directive 2004/109/EC) (DTR5.1)
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument
Conversion Period
Number of voting rights that may be acquired if the instrument is
% of voting rights
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument
Conversion Period 
Physical or cash
Number of voting rights
% of voting rights

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an “X”)

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv (please add additional rows as necessary)



% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lansdowne Partners

International Limited



Lansdowne Partners


Lansdowne Partners (UK) LLP



10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Place of completion


Date of completion

20 March 2018

Brand CEO Alan Green talks Sopheon #SPE, Feedback #FDBK & STM Group #STM on Vox Markets podcast

Brand CEO Alan Green discusses Sopheon #SPE, Feedback #FDBK & STM Group #STM with Justin Waite on the Vox Markets podcast.  Interview starts at 16 minutes 35 seconds in.

Buy Randall & Quilter #RQIH says VectorVest. Company undergoing a transformation through operational streamlining and refocusing into core areas

Bermuda-based Randall & Quilter Investment Holdings (RQIH.L) is a specialist non-life insurance acquirer, service provider and underwriting manager. RQIH generates profits and capital extractions from expert management of legacy non-life insurance acquisitions/reinsurances, including in Lloyds, and generates commission income from its licensed (and rated) carriers in the US and EU/UK, writing niche and profitable programme business, largely on behalf of highly rated reinsurers. RQIH was founded by Ken Randall and Alan Quilter in 1991.

FREE! For free VectorVest analysis on any stock, go to this link here

On January 8th 2018, RQIH announced a board restructure and said it continued to make “excellent progress, with Group simplification proceeding well, and a strong new business pipeline.” On January 15th 2018, RQIH announced the sale of its insurance services and captive management operations to digital solutions provider Davis Group. The proceed of around £18.6m will be used to help finance the group’s growing legacy transaction pipeline, especially in the US and Lloyd’s, and to generate commission income from the use of Accredited and Malta’s direct licenses. Chairman Ken Randall said: “The sale of our insurance services and captive management operations is a significant milestone in the group’s decision to simplify its operations and focus on our core areas of legacy acquisitions and the writing of quality programme business, which is mostly reinsured to highly rated reinsurers.” Separately broker Numis reiterated a buy rating and 195p target for RQIH in Feb 2018.

The sequence of moves to simplify and streamline group operations was flagged at the start of January by several key VectorVest metrics. These include RV (Relative Value) – an indicator of long-term price appreciation potential and where RQIH scores 1.57, which again is excellent on a scale of 0.00 to 2.00. RQIH also scores an excellent GRT (Earnings Growth Rate) of 34%, and while the RS (Relative Safety) metric only registers a fair rating of 0.98 (scale of 0.00 to 2.00), trading at 151p the stock is still considerably undervalued against a current VectorVest valuation of 228p per share.

The chart of RQIH.L is shown below using weekly candles over the past two years using my normal notation. The valuation is shown by the green line study above the price while earnings per share is shown by the blue line study in the window below the price. The share has charted an ascending triangle since November 2016 and looks highly probable to break upwards from this bullish formation soon.

Summary: Hot on the heels of niche finance group STM last week, VectorVest presents yet another sector play. First established in 1991, RQIH is undergoing a transformation through operational streamlining and refocusing into core areas. With a solid long-term track record, broker support and a bullish charting configuration currently playing out, VectorVest believes the stock will continue to push higher and achieve the current 228p price target by Q3 2018.

Dr David Paul

March 20th 2018

Readers can examine trading opportunities on RQIH and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 5-week trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.

FREE! For free VectorVest analysis on any stock, go to this link here

VectorVest Unisearch

On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.

Link here for more info and to set up a trial. 

European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email:

Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy

Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.

Author information  Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States; Department of Radiology, Keio University School of Medicine, Tokyo, Japan.



To compare heart and cardiac substructure radiation exposure using intensity-modulated radiotherapy (IMRT) vs. proton beam therapy (PBT) for patients with mid- to distal esophageal cancer who received chemoradiation therapy.


We identified 727 esophageal cancer patients who received IMRT (n=477) or PBT (n=250) from March 2004 to December 2015. All patients were treated to 50.4Gy with IMRT or to 50.4 cobalt Gray equivalents with PBT. IMRT and PBT dose-volume histograms (DVHs) of the whole heart, atria, ventricles, and four coronary arteries were compared. For PBT patients, passive scattering proton therapy (PSPT; n=237) and intensity-modulated proton therapy (IMPT; n=13) DVHs were compared.


Compared with IMRT, PBT resulted in significantly lower mean heart dose (MHD) and heart V5, V10, V20, V30, and V40as well as lower radiation exposure to the four chambers and four coronary arteries. Compared with PSPT, IMPT resulted in significantly lower heart V20, V30, and V40 but not MHD or heart V5 or V10. IMPT also resulted in significantly lower radiation doses to the left atrium, right atrium, left main coronary artery, and left circumflex artery, but not the left ventricle, right ventricle, left anterior descending artery, or right coronary artery. Factors associated with lower MHD included PBT (P<0.001), smaller planning target volume (PTV; P<0.001), and gastroesophageal junction (GEJ) tumor (P<0.001). Among PBT patients, factors associated with lower MHD included IMPT (P=0.038), beam arrangement other than AP/PA (P<0.001), smaller PTV (P<0.001), and GEJ tumor (P<0.001).


In patients with mid- to distal esophageal cancer, PBT results in significantly lower radiation exposure to the whole heart and cardiac substructures than IMRT. Long-term studies are necessary to determine how this cardiac sparing effect impacts the development of coronary artery disease and other cardiac complications.

Original article here

Salt Lake Potash #SO4 – Holdings in company

Salt Lake Potash Limited #SO4 advises that it was notified on 19 March 2018, via the filing of a Form 605 – Notice of ceasing to be a substantial holder with the ASX, – that on 15 March 2018, following a disposal, JP Morgan Chase & Co. and its affiliates ceased to be a substantial holder of the Company, as defined by the listing rules of the ASX. As at 15 March 2018, JP Morgan Chase & Co. and its affiliates held an interest in 8,748,416 ordinary shares of no par value each in the capital of the Company, representing 4.998 per cent of the Company’s issued share capital.

For further information please visit or contact:


Sam Cordin

Salt Lake Potash Limited

Tel: +61 8 9322 6322

Colin Aaronson/Richard Tonthat

Grant Thornton UK LLP (Nominated Adviser)

Tel: +44 (0)207 383 5100

Nick Tulloch/Beth McKiernan

Cenkos Securities plc (Joint broker)

Tel: +44 (0) 131 220 6939

Jerry Keen/Toby Gibbs

Shore Capital (Joint broker)

Tel: +44 (0 207 468 7967


This information is provided by RNS

The company news service from the London Stock Exchange

Ian Pollard – Will bullying Melrose #MRO shareholders win the day?

Melrose MRO Today the gloves are off as Melrose goes to war in its attempts to persuade GKN shareholders to abandon its company. If ever an example was needed as to how the City is no longer a place for gentlemen, Melrose provides it with a hectoring, bullying diatribe threatening GKN shareholders with the terrible financial consequences of their own folly if they are stupid enough to reject Melrose’s offer.There is only one problem and it is a problem which Melrose has created for itself. Its attitude and language is so extreme that it makes it appear that this is its last desperate throw of the dice after which its ammunition is exhausted.

Thus Melrose’s final offensive, attacks GKN’s “hastily assembled and ill considered proposals”, threatens GKN shareholders that “unless they accept our offer” there will be dire consequences and compares GKN rebuttal with what they laughingly call their own “measured approach”. In fact there is nothing measured about today’s response.  Its warnings read like the last gambit of a contestant which is running scared and knows it has already lost the battle. Rarely in the world of takeovers has a company made such a disastrous tactical error. It deliberately chose to turn itself into the beast to be feared, a wolf without any sheeps clothing. People who are threatened and treated as stupid, tend to rebel. Melrose has only itself to blame if it is rebuffed.

Finsbury Foods FIF claims that half year results to the 30th December were robust and is increasing its interim dividend by 10% to 1.1p per share. Like for like revenue rose by 2.5% and profit before tax by 6.3% as the group showed resilience in the face of a sustained period of “market wide headwinds” which it says, will persist into the future.

Weatherly International WTI announces that it may have come to the end of a long and difficult road. It renegotiated its loans from Orion on the 31st August, 30th October and 31st December and it is now faced with repayments of $20m. by the 31st March. It admits that it is unlikely to generate sufficient surplus cash to be able to meet the repayment and its continued existence as a going concern will not be possible without Orion’s continued support, of which there is no certainty.

Find beachfront villas & houses for sale in Greece;

Andrew Hore – Quoted Micro 19 March 2018


Formation Group (FRM) has been repaid its £5m loan for a development in Wembley and it retains a 40% share of the profit of the development. This cash has been used to invest in acquired a 3.44% stake in Proton Partners International, which has an operational proton beam therapy centre in South Wales with two more sites planned. A treatment unit in Abu Dhabi is expected to be launched in 2019.

Capital for Colleagues (CFCP) has loaned £600,000 to TG Engineering, which supplies steel and aluminium components to the aerospace and scientific sectors. The Dorset-based company will be 35%-owned by Capital for Colleagues and 20%-owned by the employee share ownership trust. The rest of the shares will be owned by the original founders and management.

IMC Exploration (IMCP) intends to focus on its main projects in Ireland. The interim loss was reduced from £99,000 to £75,000. There was net debt of £35,000 at the end of 2017.

Block Commodities (BLOC) has agreed to acquire a 21% stake South African fertiliser and plant products wholesaler VIPA Holdings. Block is paying £150,000 for new shares and acquiring £610,000 worth of existing shares in return for 748.5 million Block shares. VIPA is loss-making following the withdrawal of a major international trading partner. The ongoing focus will be fertiliser and the investment in Advanced Agricultural Holdings will be unwound with the 221.6 million shares issued as initial consideration returned to the company.

Primorus Investments (PRIM) has invested £500,000, at £22 a share, in Engage Technology Partners. This follows an initial subscription of £400,000 at £15 a share. Primorus owns 3.6% of Engage, which builds SaaS-based employee workflow software.

Hellenic Capital (HECP) had £272 in the bank at the end of 2017, but since then £179,000 has been raised at 0.5p a share. There was £120,000 generated from operations in 2017 but that was due to a £143,000 increase in creditors. An investment property in Leeds is in the books at £204,000, while the NAV was £58,000 at the end of 2017. The property is being sold for £235,000 and a £5,000 non-refundable deposit has been paid.

Globe Capital Ltd (GCAP) has raised £500,000 via subscription at 0.75p a share. The cash will finance a new office in Dubai. Valiant Investments (VALP) has raised £51,000 at 0.15p a share. The 84.7%-owned Flamethrower has acquired, which focuses on British railway heritage, and has nearly 10,000 registered users. Equatorial Mining and Exploration (EM.P) has raised £40,000 from an issue of 5% unsecured irredeemable convertible loan notes and a further £10,000 could come from the exercise of warrants. Via Developments (VIA1) has raised a further £590,000 from a debenture issue, taking the total raised to nearly £6m. The accounting reference date is being changed from March to September.

In 2017, Walls and Futures REIT (WAFR) achieved a total return on its portfolio of 11.5%, ahead of its benchmark total return of 7%.

DHAIS (DHAP) is leaving NEX on 18 April, nearly ten years after joining the market. The business is being streamlined and the focus is organic growth of the hearing aid operations. Shareholders owning 78.9% of DHAIS agree to the withdrawal so the company does not have to hold a general meeting.


Diurnal Group (DNL) is raising up to £11m at 190p a share in order to finance the launch of the Alkindi hormonal disease treatment for children in Europe and complete the development of Chronocourt in Europe and start a phase III study in the US. IP Group is converting its loan into shares.

Shares in VR Education (VRE) immediately went to a premium when trading commenced. It raised £6m at 10p a share and the share price ended the week at 12.25p. More than two million shares were traded during the week.

1Spatial (SPA) has sold Enables IT back to the founder for £1, while retaining a 19.9% stake. 1Spatial has also injected £150,000 into the business and loaned a further £85,000. The group will be able to focus on its geospatial data operations, which are performing better than expected. 1Spatial is on course to approach breakeven in the year to January 2019.

Marshall Motor Holdings (MMH) is outperforming new and used car markets, although like-for-like sales are still lower. Profit is expected to decline this year but Marshall should be able to continue its progressive dividend policy. There is a significant capex programme but the sale of the leasing business means that net debt is £2.2m.

Pennant International Group (PEN) already has nearly all of the £20.5m revenues forecast for 2018 covered by orders. Pre-tax profit is forecast to improve from £2.1m to £3.5m.

Amryt (AMYT) says that sales of Lojuxta were higher than expected last year. The figure was €11.9m, against the forecast €10.5m. There is still €20.5m in the bank.

Futura Medical (FUM) announced positive pharmacokinetic results for higher doses of the MED2002 erectile dysfunction treatment. This will enable US phase III trials to start later this year. There is £8.36m in cash plus tax credits due.

TechFinancials Inc (TECH) says that Cedex Holdings, where it could acquire a majority interest, has launched its token pre-sale event. One Ethereum (equivalent to £437) will equal 900 CEDEX coins. The blockchain-based online diamonds exchange says that there is strong pre-sale demand.

Genedrive (GDR) has started to sell its Genedrive HCV ID kit in the EMEA region. Sales in Asia Pacific should start in the next few weeks.

Consumer security software provider Kape Technologies (KAPE) improved its pre-tax profit from $4.8m to $6.7m. There is net cash of $69.5m. A 2018 profit of $8.3m is forecast.

Trevor Brown gas cut his stake in Feedback (FDBK) from 11.5% to 9.75%. Lindsay Melvin has taken on the role of finance director.


Advanced foams supplier Zotefoams (ZTF) continues to benefit from investment in capacity and there is more to come. There was growth from all divisions and a good spread of revenues from different sectors. In 2017, revenues were 22% higher at £70.2m, while underlying earnings per share were 14% ahead at 16.6p. The dividend is 3% higher at 5.93p a share. The partnership with Nike to develop footwear technology and supply materials is yet to make a significant contribution.

BATM Advanced Communications (BVC) returned to profit last year and both its telecoms and biomedical divisions have good growth prospects. There is $24m in cash in the bank.

Sportech (SPO) has ended its formal sales process because no suitable offers were received. Trading has been poor and there will be asset write-offs in the 2017 figures. Andrew Gaughan has been appointed as chief executive.

Flying Brands Ltd (FBDU) has acquired Imaging Biometrics for $68,134 in cash and 11 million shares at 4p each, plus $75,000 to cover debt obligations. The final 6.2 million of these shares will be paid by the end of September 2018. The Wisconsin-based company has been managing the CE marking and FDA clearance process for Flying Brands’ StoneChecker visualisation software, as well as commercialising perfusion software IB Neuro, which provides additional information about tumours.

World Trade Systems (WTS) has submitted its application to the International Stock Exchange.

Hemogenyx Pharma (HEMO) announced a collaboration that will generate $250,000 for the blood stem cell-based treatments developer. The partner is a US-based leader in the field of blood cancer treatment and the deal involves the development of a type of humanised mice.

Andrew Hore

Looking forward to Master Investor 2018

We’ll be at Master Investor 2018 tomorrow. Look forward to seeing Cadence Minerals #KDNC, VectorVest and Dr David Paul, Powerhouse Energy #PHE, Vox Markets, Core Finance TV, Share Talk, Crowd for Angels plus many other friends and colleagues.

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.